Catalent Pharma Solutions has appointed Jonathan Arnold as vice president and general manager, Sterile Technologies, effective immediately.
Catalent’s sterile technologies include blow/fill/seal capabilities and an array of injectable options, which help maximise the accuracy of sterile dosage forms and improve the quality and supply of treatments for the global pharmaceutical industry. Arnold will be located at Catalent’s corporate headquarters in Somerset, NJ, US.
Barry Littlejohns, Catalent’s president, Medication Delivery Solutions, said: ‘We are pleased to welcome Jonathan back to Catalent. We are intent on building upon Catalent’s extensive blow/fill/seal and injectable capabilities to become a leading global partner for biologic, vaccine and liquid dose form innovators worldwide.’
Arnold comes to Catalent with 20 years of experience serving the pharmaceutical and biotech industry with contract manufacturing and service solutions. His most recent role was chief procurement officer and vice president global supply chain for Patheon International.
Prior to this, Arnold was export/customer development manager for RP Scherer UK, now part of Catalent.
Jonathan Arnold returns to Catalent
As vice president and general manager of sterile technologies
